Clinical trials at the Barraquer Ophthalmology Centre
Since 1941, the Barraquer Ophthalmology Centre has specialised in the prevention, diagnosis, treatment and management of eye diseases. Since then, it has put part of its resources towards promote research, development and innovation in the Centre itself, the Barraquer Institute and through working with laboratories to roll out clinical trials.
Clinical trials are clinical studies created for the purpose of researching new medication or treatments. The aim is to make improvements to the treatment of diseases or treat pathologies for which there is no cure at present. The development phases in a clinical trial are the following:
Phase 0: The new medication is tested on animals.
Phase 1: Generally speaking, it is tested on healthy individuals, without any pathologies. The safety of the drug is analysed.
Phase 2: It is tested on individuals suffering the pathology subject to treatment. The safety and efficacy of the medication is verified.
Phase 3 or the pre-commercial phase: It is tested on a larger number of individuals suffering the pathology to be treated. The safety and efficacy is checked, before selling the drug.
Phase 4 or the post-commercial phase: Long-term studies on the safety and efficacy on sick individuals.
The risks of participating in a clinical study depend on the nature of the drug and the trial development phase. However, it is important to point out that the risk-benefit relation must always show signs of leaning towards a benefit. The benefits include: 24h personalised care, a free and exhaustive check-up and, above all, therapeutic benefits because the drugs studied could cure a disease that has been incurable until present, etc.
At the Barraquer Ophthalmology Centre, clinical trials at stages 2, 3 and 4 are currently being conducted.
Coordinator of clinical trials and member of the Ethical Committee of Barraquer